Skip to content
Open in App
Amgen logo

Amgen

web2

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The co...

Symbol · AMGN
Company profile

About

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company’s principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet’s disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including PROLIA, REPATHA, OTEZLA, ENBREL, EVENITY, XGEVA, TEPEZZA, BLINCYTO, NPLATE, TEZSPIRE, KYPROLIS, ARANESP, KRYSTEXXA AND VECTIBIX, MVASI, PAVBLU, UPLIZNA, IMDELLTRA/IMDYLLTRA, AMJEVITA/AMGEVITA, TAVNEOS, NEULASTA, LUMAKRAS/LUMYKRAS, RAVICTI, PARSABIV, AIMOVIG, WEZLANA/WEZENLA, AND PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; BEONE MEDICINES LTD. to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. The company was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Explore by sector

Explore this sector

Presentation

Watch Amgen

Market identity

Exchange listings

Listing identities only. Orbitrum does not publish live prices or market performance on this public profile.

Progress

Roadmap

CHMP supports broader European use of Repatha

KEY STEP

The European Medicines Agency’s Committee for Medicinal Products for Human Use adopted a positive opinion recommending broader cardiovascular risk reduction use of Repatha in adults with established or high risk atherosclerotic cardiovascular disease.

Roadmap reference

VESALIUS CV mortality analysis presented at ESC Congress 2026

KEY STEP

A prespecified analysis of the Phase 3 VESALIUS CV trial found lower all cause mortality with evolocumab in high risk patients without a previous heart attack or stroke. The findings were presented at ESC Congress 2026 and published in Circulation.

Roadmap reference
People

Company team

WM

Wanda M. Austin

Independent Director

Company leadership profile.

GC

Gregory C. Garland

Independent Director

Company leadership profile.

EJ

Ellen J. Kullman

Independent Director

Company leadership profile.

RA

Robert A. Bradway

Chairman & CEO

Company leadership profile.

RA

Robert A. Eckert

Lead Independent Director

Company leadership profile.

CM

Charles M. Holley

Independent Director

Company leadership profile.

CE

Charles Elliott Sigal

Co-Chair of the Scientific Advisory Board

Company leadership profile.

JS

Jonathan S. Weissman

Co-Chair of the Scientific Advisory Board

Company leadership profile.

TE

Tyler E. Jacks

Independent Director

Company leadership profile.

RS

R. Sanders Williams

Member of Scientific Advisory Board of Cardiovascular & Metabolic

Company leadership profile.

BJ

Brian J. Druker

Independent Director

Company leadership profile.

AE

Amy E. Miles

Independent Director

Company leadership profile.

SO

S. Omar Ishrak

Independent Director

Company leadership profile.

SG

S. Gail Eckhardt

Member of Scientific Advisory Board of Oncology

Company leadership profile.

MV

Michael V. Drake

Independent Director

Company leadership profile.

DJ

Diane J. Mathis

Member of Scientific Advisory Board of Inflammation

Company leadership profile.

LL

Lillian L. Siu

Member of Scientific Advisory Board of Oncology

Company leadership profile.

EG

Emma Guttman-Yassky

Member of Scientific Advisory Board of Inflammation

Company leadership profile.

AM

Alexander Marson

Member of Scientific Advisory Board of Inflammation

Company leadership profile.

AR

Alexander Rudensky

Member of Scientific Advisory Board of Inflammation

Company leadership profile.

AS

Arlene Sharpe

Member of Scientific Advisory Board of Inflammation

Company leadership profile.

DS

Dean Sheppard

Member of Scientific Advisory Board of Inflammation

Company leadership profile.

MT

Maria T. Abreu

Member of Scientific Advisory Board of Inflammation

Company leadership profile.

GG

George Georgiou

Member of Scientific Advisory Board of Research Trends & Emerging Technologies

Company leadership profile.

SH

Siwen Hu-Lieskovan

Member of Scientific Advisory Board of Oncology

Company leadership profile.

MR

Marlene Rabinovitch

Member of Scientific Advisory Board of Cardiovascular & Metabolic

Company leadership profile.

BV

Benoit Van den Eynde

Member of Scientific Advisory Board of Oncology

Company leadership profile.

AR

Antoni Ribas

Member of Scientific Advisory Board of Oncology

Company leadership profile.

RS

Robert S. Negrin

Member of Scientific Advisory Board of Oncology

Company leadership profile.

AM

Andrew Mark Pardoll

Member of Scientific Advisory Board of Oncology

Company leadership profile.

DJ

Dirk Jäger

Member of Scientific Advisory Board of Oncology

Company leadership profile.

DA

David Alan Kass

Member of Scientific Advisory Board of Cardiovascular & Metabolic

Company leadership profile.

DP

Daniel P. Kelly

Member of Scientific Advisory Board of Cardiovascular & Metabolic

Company leadership profile.

TQ

Thomas Quertermous

Member of Scientific Advisory Board of Cardiovascular & Metabolic

Company leadership profile.

PL

Peter Libby

Member of Scientific Advisory Board of Cardiovascular & Metabolic

Company leadership profile.

JD

Jeffery D. Molkentin

Member of Scientific Advisory Board of Cardiovascular & Metabolic

Company leadership profile.

DJ

Daniel Joshua Drucker

Member of Scientific Advisory Board of Cardiovascular & Metabolic

Company leadership profile.

ED

E. Dale Abel

Member of Scientific Advisory Board of Cardiovascular & Metabolic

Company leadership profile.

FP

Frank P. McCormick

Member of Scientific Advisory Board of Research Trends & Emerging Technologies

Company leadership profile.

DJ

David J. Anderson

Member of Scientific Advisory Board of Research Trends & Emerging Technologies

Company leadership profile.

RM

Ronald M. Evans

Member of Scientific Advisory Board of Research Trends & Emerging Technologies

Company leadership profile.

ME

Mary Earley Klotman

Independent Director

Company leadership profile.

FA

Fabrice Andre

Member of Scientific Advisory Board of Oncology

Company leadership profile.

RJ

Randy J. Seeley

Member of Scientific Advisory Board

Company leadership profile.

VG

Viviana Gradinaru

Member of Scientific Advisory Board of Research Trends & Emerging Technologies

Company leadership profile.

ES

Eran Segal

Member of Scientific Advisory Board of Research Trends & Emerging Technologies

Company leadership profile.

PZ

Philip Zamore

Member of Scientific Advisory Board of Research Trends & Emerging Technologies

Company leadership profile.

DJ

David J. Mooney

Member of Scientific Advisory Board of Research Trends & Emerging Technologies

Company leadership profile.

JZ

James Zou

Member of Scientific Advisory Board of Research Trends & Emerging Technologies

Company leadership profile.

PH

Patrick Hsu

Member of Scientific Advisory Board of Research Trends & Emerging Technologies

Company leadership profile.

Expert coverage

2 experts evaluated Amgen.

Orbitrum research

Experts evaluating Amgen

Explore the public profiles of experts who have evaluated this project.

Orbitrum Academy

Learn how to read a project assessment